Royalty Pharma Dividend yield




   USD/share 
 Price  43.62
 Dividend  0.51
 Earnings  1.33
 Cash-flow  5.26
 Book value  12.46
 Equity  14.00

Royalty Pharma is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Royalty Pharma is a company from USA, and his stocks are publicly traded.

Royalty Pharma paid a total dividend of 198 million USD last year, for a market value of 16,925 millions (Market Cap 13,937 millions). Dividend per share of Royalty Pharma is 0.51 USD, and his stock market price 43.62 USD.

According to the chart below, where dividend yield is displayed, Royalty Pharma has a dividend yield of 1.17%, lower than the amount offered by both the market average and companies from USA. It is also lower than average of Health Care industry. This low dividend yield might has several explanations: company overpriced, expanding their business,...

In addition, you should compare Royalty Pharma dividend yield with other Pharmaceuticals and Biotechnology companies or firms from USA.

Dividend yield of Royalty Pharma

Royalty Pharma Dividend Payout

About the ability of Royalty Pharma to maintain his current dividend of USD 0.51 per share, an amount that accounts for 1.17%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Royalty Pharma payout on ernings is currently 38.35%, which is higher than the market average, and companies of Health Care industry, which are 38.17% and 28.58% respectively. Both figures show that Royalty Pharma can have problems to keep with his present dividend yield.

The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of Royalty Pharma is USD 5.26 per share, which is higher than the dividend per share paid by the company of USD 0.51, so the company generates enough cash to maintain his dividend in the future.

The following figure shows payout ratios over earnings and cashflow of Royalty Pharma, compared againt world market average, USA companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

Royalty Pharma payout

Royalty Pharma Dividend History

No data available

Royalty Pharma Stock performance

Finally, last moth Royalty Pharma showed a return of -6.30% compared to a worldwide 4.24% average, and a 3.00% of Health Care firms. Over the last year, the company obtained a 0.00% versus a worldwide performance of a 53.49%. More detailed information can be seen in the following graph for USA and Pharmaceuticals and Biotechnology firms.

Royalty Pharma stock and market return